Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kadi Dick
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
OpenAlex ID:
A5137130701
MC1923: Phase II durvalumab plus lurbinectedin in platinum-resistant relapsed extensive-stage small cell lung cancer after prior chemoimmunotherapy (cohort B).
2026
·
Konstantinos Leventakos
, Anastasios Dimou
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
1
Citation count:
H-index:
I10-index:
Year
Topic
Type
